SL
NWBO

Sentinus LLC’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Sentinus LLC’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,925
Closed -$3.55K – 210
2024
Q4 		$3.55K Buy
+12,925
New +$3.55K ﹤0.01% 182
2024
Q3 		– Sell
-12,925
Closed -$5.52K – 197
2024
Q2 		$5.52K Buy
+12,925
New +$5.52K ﹤0.01% 182
2023
Q2 		$1.4M Buy
2,469,440
+279,000
+13% +$158K 0.44% 42
2023
Q1 		$1.37M Buy
2,190,440
+395,650
+22% +$247K 0.46% 46
2022
Q4 		$1.45M Buy
1,794,790
+600,375
+50% +$484K 0.85% 30
2022
Q3 		$1.02M Buy
+1,194,415
New +$1.02M 0.64% 36

Other funds holding NWBO

MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $335M AUM 16.18% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $549M AUM 29.35% 1-Year Est. Return